Olvi (OLVAS) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
19 Jan, 2026Executive summary
Profitability improved in line with targets, with adjusted operating result up 21.5% for Jan–Sep and EBIT rising 53% year-over-year, supported by operational efficiency, price and portfolio optimization, and favorable weather.
Net sales rose 2.8% for Jan–Sep, with market share maintained or grown in key segments, especially non-alcoholic products.
Strategy focused on people, data, and process improvements, aiming to restore profitability to pre-COVID levels.
Financial highlights
Jan–Sep net sales: €510.0m (+2.8% y/y); Q3 net sales: €184.9m (+8.1% y/y).
Adjusted EBIT grew nearly 22% for Jan–Sep, and EBIT rose 53% year-over-year, with last year's EBIT impacted by a €12.2m fine in Belarus.
Earnings per share returned to a more normal level at €2.62 (+70.1% y/y), up from a fine-impacted prior year.
Cash flow from operating activities increased to €64.8m (vs. €10.6m y/y), driven by higher operating results and working capital changes.
Outlook and guidance
Adjusted operating result for 2024 expected at €78–84m, raised from previous €74–80m.
Profitability improvements are visible, but further steps are needed to reach pre-COVID levels.
Economic outlook for the Baltic region and Finland is expected to improve slightly next year.
Latest events from Olvi
- 2025 saw higher sales, profit, and acquisitions, with strong Q4 and positive 2026 outlook.OLVAS
Q4 202527 Feb 2026 - Profitability rose 8.8% in H1 2024, with stable sales and strong financials amid market challenges.OLVAS
Q2 20241 Feb 2026 - Profitability and margins improved, with €82–90M profit guidance and a €1.30 dividend proposed.OLVAS
Q4 202423 Dec 2025 - Profitability rose 10.9% as net sales grew and 2025 profit guidance remains unchanged.OLVAS
Q1 202523 Dec 2025 - Stable net sales and strong market shares offset by lower volumes and reduced profitability.OLVAS
Q2 202523 Nov 2025 - Profitability declined despite stable sales, with guidance lowered due to weak demand and higher costs.OLVAS
Q3 202522 Oct 2025